A Philadelphia jury has handed up a $57.1 million verdict against Johnson & Johnson subsidiary Ethicon after a trial over allegations that its transvaginal mesh product was defective.

The jury award, handed up Thursday in Ebaugh v. Ethicon, was composed of $7.1 million in compensatory damages and $50 million in punitive damages.

According to a review of The Legal's archives, the verdict is a record award for the pelvic mesh program in Philadelphia, which has seen several multimillion-dollar verdicts since the first pelvic-mesh-related case was tried in late 2015. The verdict is more than twice the second-largest award out of the program, a $20 million verdict a jury handed up in May.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Go To Lexis →

Not a Lexis Subscriber?
Subscribe Now

Go To Bloomberg Law →

Not a Bloomberg Law Subscriber?
Subscribe Now

NOT FOR REPRINT